Literature DB >> 14704869

Epidemiology of cardiovascular complications in type 2 diabetes mellitus.

J B Meigs1.   

Abstract

Type 2 diabetes is increasing in epidemic proportions worldwide, and is strongly associated with atherosclerotic cardiovascular disease (CVD). Hyperglycaemia increases risk of CVD, but glycaemic control does not substantially reduce CVD risk. There are several potential explanations for this apparent paradox, including the roles of the metabolic syndrome and post-load hyperglycaemia in the association of type 2 diabetes and CVD.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14704869     DOI： 10.1007/s00592-003-0120-0

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN： 0940-5429            Impact factor:   4.280


  18 in total

1.  Early signs of cardiovascular disease in youth with obesity and type 2 diabetes.

Authors:  Neslihan Gungor; Trina Thompson; Kim Sutton-Tyrrell; Janine Janosky; Silva Arslanian
Journal:  Diabetes Care       Date:  2005-05       Impact factor: 19.112

Review 2.  Blood pressure and cardiovascular effects of new and emerging antidiabetic agents.

Authors:  Pelbreton C Balfour; Carlos J Rodriguez; Keith C Ferdinand
Journal:  Curr Hypertens Rep       Date:  2014-08       Impact factor: 5.369

Review 3.  Cardiovascular disease in children and adolescents with diabetes: where are we, and where are we going?

Authors:  Uyen T Truong; David M Maahs; Stephen R Daniels
Journal:  Diabetes Technol Ther       Date:  2012-06       Impact factor: 6.118

4.  Cardiovascular safety of dipeptidyl peptidase-4 inhibitors: recent evidence on heart failure.

Authors:  Saumya Reddy Kankanala; Rafay Syed; Quan Gong; Boxu Ren; Xiaoquan Rao; Jixin Zhong
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

Review 5.  Cardiovascular safety of therapies for type 2 diabetes.

Authors:  Puneet Gupta; William B White
Journal:  Expert Opin Drug Saf       Date:  2016-10-11       Impact factor: 4.250

6.  Cost-Effectiveness of Empagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus at Increased Cardiovascular Risk in Greece.

Authors:  George Gourzoulidis; Charalampos Tzanetakos; Ioannis Ioannidis; Apostolos Tsapas; Georgia Kourlaba; Giannis Papageorgiou; Nikos Maniadakis
Journal:  Clin Drug Investig       Date:  2018-05       Impact factor: 2.859

7.  Sitagliptin After Ischemic Stroke in Type 2 Diabetic Patients: A Nationwide Cohort Study.

Authors:  Dong-Yi Chen; Szu-Heng Wang; Chun-Tai Mao; Ming-Lung Tsai; Yu-Sheng Lin; Feng-Chieh Su; Chung-Chuan Chou; Ming-Shien Wen; Chun-Chieh Wang; I-Chang Hsieh; Kuo-Chun Hung; Wen-Jin Cherng; Tien-Hsing Chen
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

Review 8.  Cardiovascular disease in diabetes, beyond glucose.

Authors:  Robert H Eckel; Karin E Bornfeldt; Ira J Goldberg
Journal:  Cell Metab       Date:  2021-07-21       Impact factor: 31.373

9.  Predictive value of coronary calcifications for future cardiac events in asymptomatic patients with diabetes mellitus: a prospective study in 716 patients over 8 years.

Authors:  Alexander Becker; Alexander W Leber; Christoph Becker; Franz von Ziegler; Janine Tittus; Ines Schroeder; Gerhard Steinbeck; Andreas Knez
Journal:  BMC Cardiovasc Disord       Date:  2008-10-10       Impact factor: 2.298

10.  Increased risk of acute coronary syndrome among patients with urinary stone disease: a nationwide population-based cohort study.

Authors:  Shun-Fa Hung; Chao-Yuan Huang; Cheng-Li Lin; Shiu-Dong Chung; Chi-Jung Chung; Chia-Hung Kao; Chao-Hsiang Chang
Journal:  PLoS One       Date:  2014-07-10       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.